In cancer, stress-enhanced EVs secretion has been associated with increased tumor aggressiveness, through the delivery of oncogenic proteins, TGF-β, and immunomodulatory miRNAs that promote stromal remodeling and immune evasion [35]. This evidence concerns the gene TGFB1 and neoplasm.